Reporting from ELCC 2019 in Geneva, C. Lindsay comments on the results of a multicentre study which aimed to analyse circulating tumour cells in advanced NSCLC and their potential clinical role. He also showed results from a study analysing plasma ctDNA in advanced NSCLC patients with isolated CNS metastases.
ESMO Expert video report on CTC and ctDNA in advanced NSCLC